These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5085437)

  • 1. [Effects of oxyfedrin on hemodynamics and myocardial and hepatic metabolism in intact dogs after beta-adrenergic blockade].
    Niessner H; Raberger G; Lujf A; Moser K
    Res Exp Med (Berl); 1972; 158(4):288-97. PubMed ID: 5085437
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of oxyfedrin on hemodynamics and myocardial and hepatic metabolism in dogs].
    Niessner H; Raberger G; Lujf A; Moser K
    Z Gesamte Exp Med Einschl Exp Chir; 1971; 155(4):304-14. PubMed ID: 5096324
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental studies of the modification of myocardial metabolism with oxyfedrin].
    Niessner H; Lujf A; Moser K
    Z Gesamte Exp Med Einschl Exp Chir; 1969; 151(2):163-74. PubMed ID: 5357616
    [No Abstract]   [Full Text] [Related]  

  • 4. General and coronary haemodynamic effects of 1-(O-allyloxphenoxy)-3-isopropylamino-2-propanol hydrochloride.
    Maxwell GM
    Arch Int Pharmacodyn Ther; 1968 May; 173(1):226-31. PubMed ID: 5657822
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of a new beta-receptor blocking substance on human hemodynamics and metabolism].
    Niessner H; Lujf A; Moser K
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):277-81. PubMed ID: 4394123
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of three vaporizable fire extinguishing agents on myocardial metabolism and cardiovascular dynamics in the anesthetized dog.
    Van Stee EW; Harris AM; Horton ML; Back KC
    Toxicol Appl Pharmacol; 1975 Oct; 34(1):62-71. PubMed ID: 1198616
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic and coronary hemodynamic effects of pronethalol practolol, sotalol and D-propranolol.
    Rowe GG; Berndt TB; O'Brien GS; Afonso S
    Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):5-24. PubMed ID: 4404935
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic and coronary hemodynamic effects of glucagon.
    Rowe GG
    Am J Cardiol; 1970 Jun; 25(6):670-4. PubMed ID: 5420906
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective metabolic and cardiovascular beta receptor antagonism in the rat.
    Stanton HC
    Arch Int Pharmacodyn Ther; 1972 Apr; 196(2):246-58. PubMed ID: 4401080
    [No Abstract]   [Full Text] [Related]  

  • 10. [Myocardial oxygen and substrate metabolism in patients with aortic valve stenosis].
    Rudolph W; Wicklmayr M
    Z Kreislaufforsch; 1969 Mar; 58(3):252-66. PubMed ID: 5772011
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of beta-adrenergic blockade on myocardial haemodynamics and metabolism during light halothane anaesthesia.
    Merin RG; Tonnesen AS
    Can Anaesth Soc J; 1969 Jul; 16(4):336-44. PubMed ID: 5807476
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of Althesin (Glaxo CT 1341) on coronary blood flow and myocardial metabolism in man.
    Sonntag H; Schenk HD; Regensburger D; Kettler D; Hellberg K; Knoll D; Donath U; Becker H
    Acta Anaesthesiol Scand; 1973; 17(4):218-26. PubMed ID: 4774046
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in the total metabolism, blood gases and myocardial metabolism following beta receptor blockade in man].
    Neubaur J; Winter A; Kochsiek K
    Klin Wochenschr; 1970 Feb; 48(3):167-71. PubMed ID: 5523132
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of a new xanthine derivative, 3,7-dimethyl-1(5-oxohexyl)-xanthin (pentoxifylline) on the general and cardiac haemodynamics of the intact animal.
    Maxwell GM
    Aust J Exp Biol Med Sci; 1975 Aug; 53(4):265-71. PubMed ID: 1230139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of heptaminol hydrochloride on general, pulmonary and coronary hemodynamics and its effect on heart metabolism].
    Pourrias B; Sergant M; Raynaud G
    Int Z Klin Pharmakol Ther Toxikol; 1970 May; 3(2):190-6. PubMed ID: 5425959
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of prostaglandin E1 upon the general and coronary haemodynamics and metabolism of the intact dog.
    Maxwell GM
    Br J Pharmacol Chemother; 1967 Sep; 31(1):162-8. PubMed ID: 6055250
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemodynamic and metabolic effects of beta-adrenergic blockade in exercising dogs.
    Cronin RF
    J Appl Physiol; 1967 Feb; 22(2):211-6. PubMed ID: 6017885
    [No Abstract]   [Full Text] [Related]  

  • 18. [Substrate metabolism in the human heart under the effect of hexobendin].
    Rudolph W; Marko I
    Arzneimittelforschung; 1970 Sep; 20(9):1190-8. PubMed ID: 5536795
    [No Abstract]   [Full Text] [Related]  

  • 19. The acute hemodynamic effects of oxyfedrine.
    Cole JS; Kennedy JW
    J Clin Pharmacol New Drugs; 1971; 11(6):417-22. PubMed ID: 5211288
    [No Abstract]   [Full Text] [Related]  

  • 20. Myocardial uptake of free fatty acids and carbohydrates after beta adrenergic blockade.
    Marchetti G; Merlo L; Noseda V
    Am J Cardiol; 1968 Sep; 22(3):370-4. PubMed ID: 5667913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.